CORT
Corcept Therapeutics Incorporated$117.85+24.73 (+26.61%)Prev Close$92.95·MCap$9.78B·P/E336.71·Vol3.73M·Yield—
▲
Buys (12M)
1
$3.31M
▼
Sells (12M)
56
$104.52M
◆
Net Activity
Net Seller
$101.21M
●
Active Insiders
12
last 12 mo
Over the past 12 months, insider activity at Corcept Therapeutics Incorporated (CORT) has been dominated by selling, with 1 insider purchase totaling $3.31M and 56 insider sales totaling $104.52M. The most recent insider transaction was by WILSON JAMES N (director), who sold $883.0K worth of shares on Jul 17, 2026. Corcept Therapeutics Incorporated operates in the Healthcare sector, within the Medical - Pharmaceuticals industry, with a market cap of $9.78B.
CORT Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 17, 2026 | WILSON JAMES N | director | Sell | 10,000 | $88.30 | $883.0K | 1,093,464 |
| Jul 17, 2026 | Mokari Atabak | officer: Chief Financial Officer | Sell | 40,000 | $87.71 | $3.51M | 48,211-45% |
| Jul 8, 2026 | Guyer William | officer: Chief Development Officer | Sell | 20,000 | $93.13 | $1.86M | 4,937-80% |
| Jul 6, 2026 | Maduck Sean | officer: See Remarks | Sell | 25,000 | $88.35 | $2.21M | 23,731-51% |
| Jun 18, 2026 | MAHONEY DAVID L | director | Sell | 20,000 | $84.53 | $1.69M | 26,147-43% |
| Jun 18, 2026 | WILSON JAMES N | director | Sell | 10,000 | $83.20 | $832.0K | 1,100,366 |
| Jun 17, 2026 | Mokari Atabak | officer: Chief Financial Officer | Sell | 40,000 | $81.15 | $3.25M | 46,696-46% |
| Jun 4, 2026 | Guyer William | officer: Chief Development Officer | Sell | 20,000 | $70.60 | $1.41M | 3,985-83% |
| Jun 3, 2026 | Maduck Sean | officer: See Remarks | Sell | 25,000 | $70.21 | $1.76M | 12,908-66% |
| Jun 3, 2026 | Mokari Atabak | officer: Chief Financial Officer | Sell | 40,000 | $70.00 | $2.80M | 15,257-72% |
| Jun 2, 2026 | BELANOFF JOSEPH K | director, officer: Chief Executive Officer | Sell | 12,837 | $69.74 | $895.3K | 2,565,489 |
| May 29, 2026 | Lyon Joseph Douglas | officer: See Remarks | Sell | 5,000 | $65.00 | $325.0K | 6,230-45% |
| May 29, 2026 | Maduck Sean | officer: See Remarks | Sell | 75,000 | $65.59 | $4.92M | 29,402-72% |
| May 7, 2026 | Guyer William | officer: Chief Development Officer | Sell | 20,000 | $51.83 | $1.04M | 2,231-90% |
| May 5, 2026 | BELANOFF JOSEPH K | director, officer: Chief Executive Officer | Sell | 40,000 | $50.10 | $2.00M | 2,878,326 |
| Apr 8, 2026 | Guyer William | officer: Chief Development Officer | Sell | 20,000 | $40.97 | $819.4K | 2,231-90% |
| Mar 27, 2026 | BELANOFF JOSEPH K | director, officer: Chief Executive Officer | Sell | 26,198 | $50.07 | $1.31M | 2,918,326 |
| Mar 24, 2026 | Guyer William | officer: Chief Development Officer | Sell | 11,767 | $36.01 | $423.7K | 2,231-84% |
| Mar 19, 2026 | BAKER G LEONARD JR | director | Buy | 100,000 | $33.14 | $3.31M | 1,146,631 |
| Mar 6, 2026 | Guyer William | officer: Chief Development Officer | Sell | 8,233 | $35.99 | $296.3K | 2,231-79% |
| Feb 9, 2026 | Hunt Hazel | Chief Scientific Officer | Sell | 77,968 | $41.31 | $3.22M | 0 |
| Feb 5, 2026 | Guyer William | officer: Chief Development Officer | Sell | 20,000 | $40.87 | $817.3K | 1,235-94% |
| Feb 3, 2026 | Guyer William | Chief Development Officer | Sell | 20,000 | $40.87 | $817.3K | 0 |
| Jan 8, 2026 | Guyer William | officer: Chief Development Officer | Sell | 20,000 | $35.18 | $703.7K | 1,235-94% |
| Jan 6, 2026 | Guyer William | Chief Development Officer | Sell | 20,000 | $35.18 | $703.7K | 0 |
| Dec 24, 2025 | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 306,846 | $83.59 | $25.65M | 0 |
| Dec 24, 2025 | Robb Gary Charles | Chief Business Officer | Sell | 80,284 | $83.59 | $6.71M | 0 |
| Dec 1, 2025 | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 40,000 | $79.77 | $3.19M | 0 |
| Dec 1, 2025 | Guyer William | Chief Development Officer | Sell | 20,000 | $80.08 | $1.60M | 0 |
| Dec 1, 2025 | Lyon Joseph Douglas | See Remarks | Sell | 5,110 | $79.53 | $406.4K | 0 |
| Dec 1, 2025 | Maduck Sean | See Remarks | Sell | 20,135 | $79.53 | $1.60M | 0 |
| Dec 1, 2025 | Mokari Atabak | Chief Financial Officer | Sell | 118 | $79.78 | $9.4K | 0 |
| Dec 1, 2025 | Robb Gary Charles | Chief Business Officer | Sell | 148 | $79.78 | $11.8K | 0 |
| Nov 25, 2025 | Guyer William | Chief Development Officer | Sell | 4,500 | $80.90 | $364.1K | 0 |
| Nov 5, 2025 | Guyer William | Chief Development Officer | Sell | 20,000 | $75.36 | $1.51M | 0 |
| Nov 3, 2025 | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 40,000 | $74.58 | $2.98M | 0 |
| Nov 3, 2025 | Lyon Joseph Douglas | See Remarks | Sell | 5,000 | $73.65 | $368.2K | 0 |
| Nov 3, 2025 | Maduck Sean | See Remarks | Sell | 20,000 | $73.99 | $1.48M | 0 |
| Oct 10, 2025 | Swisher Daniel N JR | Director | Sell | 2,200 | $87.54 | $192.6K | 0 |
| Oct 7, 2025 | Guyer William | Chief Development Officer | Sell | 20,000 | $89.94 | $1.80M | 0 |
| Oct 1, 2025 | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 40,000 | $85.08 | $3.40M | 0 |
| Oct 1, 2025 | Lyon Joseph Douglas | See Remarks | Sell | 5,000 | $84.75 | $423.8K | 0 |
| Oct 1, 2025 | Maduck Sean | See Remarks | Sell | 20,000 | $85.06 | $1.70M | 0 |
| Sep 10, 2025 | Swisher Daniel N JR | Director | Sell | 2,200 | $72.45 | $159.4K | 0 |
| Sep 4, 2025 | Cannon Gillian | Director | Sell | 3,607 | $70.13 | $253.0K | 0 |
| Sep 2, 2025 | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 40,000 | $70.53 | $2.82M | 0 |
| Sep 2, 2025 | Guyer William | Chief Development Officer | Sell | 20,000 | $70.49 | $1.41M | 0 |
| Sep 2, 2025 | Lyon Joseph Douglas | See Remarks | Sell | 5,189 | $70.29 | $364.7K | 0 |
| Sep 2, 2025 | Maduck Sean | See Remarks | Sell | 20,233 | $70.50 | $1.43M | 0 |
| Sep 2, 2025 | Mokari Atabak | Chief Financial Officer | Sell | 144 | $71.38 | $10.3K | 0 |
Showing 1–50 of 200
1 / 4
CORT Insider Buying Activity
The following table shows recent insider purchases of Corcept Therapeutics Incorporated (CORT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 19, 2026 | BAKER G LEONARD JR | director | Buy | 100,000 | $33.14 | $3.31M | 1,146,631 |
CORT Insider Selling Activity
The following table shows recent insider sales of Corcept Therapeutics Incorporated (CORT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 17, 2026 | WILSON JAMES N | director | Sell | 10,000 | $88.30 | $883.0K | 1,093,464 |
| Jul 17, 2026 | Mokari Atabak | officer: Chief Financial Officer | Sell | 40,000 | $87.71 | $3.51M | 48,211-45% |
| Jul 8, 2026 | Guyer William | officer: Chief Development Officer | Sell | 20,000 | $93.13 | $1.86M | 4,937-80% |
| Jul 6, 2026 | Maduck Sean | officer: See Remarks | Sell | 25,000 | $88.35 | $2.21M | 23,731-51% |
| Jun 18, 2026 | MAHONEY DAVID L | director | Sell | 20,000 | $84.53 | $1.69M | 26,147-43% |
| Jun 18, 2026 | WILSON JAMES N | director | Sell | 10,000 | $83.20 | $832.0K | 1,100,366 |
| Jun 17, 2026 | Mokari Atabak | officer: Chief Financial Officer | Sell | 40,000 | $81.15 | $3.25M | 46,696-46% |
| Jun 4, 2026 | Guyer William | officer: Chief Development Officer | Sell | 20,000 | $70.60 | $1.41M | 3,985-83% |
| Jun 3, 2026 | Maduck Sean | officer: See Remarks | Sell | 25,000 | $70.21 | $1.76M | 12,908-66% |
| Jun 3, 2026 | Mokari Atabak | officer: Chief Financial Officer | Sell | 40,000 | $70.00 | $2.80M | 15,257-72% |
| Jun 2, 2026 | BELANOFF JOSEPH K | director, officer: Chief Executive Officer | Sell | 12,837 | $69.74 | $895.3K | 2,565,489 |
| May 29, 2026 | Lyon Joseph Douglas | officer: See Remarks | Sell | 5,000 | $65.00 | $325.0K | 6,230-45% |
| May 29, 2026 | Maduck Sean | officer: See Remarks | Sell | 75,000 | $65.59 | $4.92M | 29,402-72% |
| May 7, 2026 | Guyer William | officer: Chief Development Officer | Sell | 20,000 | $51.83 | $1.04M | 2,231-90% |
| May 5, 2026 | BELANOFF JOSEPH K | director, officer: Chief Executive Officer | Sell | 40,000 | $50.10 | $2.00M | 2,878,326 |
| Apr 8, 2026 | Guyer William | officer: Chief Development Officer | Sell | 20,000 | $40.97 | $819.4K | 2,231-90% |
| Mar 27, 2026 | BELANOFF JOSEPH K | director, officer: Chief Executive Officer | Sell | 26,198 | $50.07 | $1.31M | 2,918,326 |
| Mar 24, 2026 | Guyer William | officer: Chief Development Officer | Sell | 11,767 | $36.01 | $423.7K | 2,231-84% |
| Mar 6, 2026 | Guyer William | officer: Chief Development Officer | Sell | 8,233 | $35.99 | $296.3K | 2,231-79% |
| Feb 9, 2026 | Hunt Hazel | Chief Scientific Officer | Sell | 77,968 | $41.31 | $3.22M | 0 |
| Feb 5, 2026 | Guyer William | officer: Chief Development Officer | Sell | 20,000 | $40.87 | $817.3K | 1,235-94% |
| Feb 3, 2026 | Guyer William | Chief Development Officer | Sell | 20,000 | $40.87 | $817.3K | 0 |
| Jan 8, 2026 | Guyer William | officer: Chief Development Officer | Sell | 20,000 | $35.18 | $703.7K | 1,235-94% |
| Jan 6, 2026 | Guyer William | Chief Development Officer | Sell | 20,000 | $35.18 | $703.7K | 0 |
| Dec 24, 2025 | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 306,846 | $83.59 | $25.65M | 0 |
| Dec 24, 2025 | Robb Gary Charles | Chief Business Officer | Sell | 80,284 | $83.59 | $6.71M | 0 |
| Dec 1, 2025 | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 40,000 | $79.77 | $3.19M | 0 |
| Dec 1, 2025 | Guyer William | Chief Development Officer | Sell | 20,000 | $80.08 | $1.60M | 0 |
| Dec 1, 2025 | Lyon Joseph Douglas | See Remarks | Sell | 5,110 | $79.53 | $406.4K | 0 |
| Dec 1, 2025 | Maduck Sean | See Remarks | Sell | 20,135 | $79.53 | $1.60M | 0 |
| Dec 1, 2025 | Mokari Atabak | Chief Financial Officer | Sell | 118 | $79.78 | $9.4K | 0 |
| Dec 1, 2025 | Robb Gary Charles | Chief Business Officer | Sell | 148 | $79.78 | $11.8K | 0 |
| Nov 25, 2025 | Guyer William | Chief Development Officer | Sell | 4,500 | $80.90 | $364.1K | 0 |
| Nov 5, 2025 | Guyer William | Chief Development Officer | Sell | 20,000 | $75.36 | $1.51M | 0 |
| Nov 3, 2025 | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 40,000 | $74.58 | $2.98M | 0 |
| Nov 3, 2025 | Lyon Joseph Douglas | See Remarks | Sell | 5,000 | $73.65 | $368.2K | 0 |
| Nov 3, 2025 | Maduck Sean | See Remarks | Sell | 20,000 | $73.99 | $1.48M | 0 |
| Oct 10, 2025 | Swisher Daniel N JR | Director | Sell | 2,200 | $87.54 | $192.6K | 0 |
| Oct 7, 2025 | Guyer William | Chief Development Officer | Sell | 20,000 | $89.94 | $1.80M | 0 |
| Oct 1, 2025 | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 40,000 | $85.08 | $3.40M | 0 |
| Oct 1, 2025 | Lyon Joseph Douglas | See Remarks | Sell | 5,000 | $84.75 | $423.8K | 0 |
| Oct 1, 2025 | Maduck Sean | See Remarks | Sell | 20,000 | $85.06 | $1.70M | 0 |
| Sep 10, 2025 | Swisher Daniel N JR | Director | Sell | 2,200 | $72.45 | $159.4K | 0 |
| Sep 4, 2025 | Cannon Gillian | Director | Sell | 3,607 | $70.13 | $253.0K | 0 |
| Sep 2, 2025 | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 40,000 | $70.53 | $2.82M | 0 |
| Sep 2, 2025 | Guyer William | Chief Development Officer | Sell | 20,000 | $70.49 | $1.41M | 0 |
| Sep 2, 2025 | Lyon Joseph Douglas | See Remarks | Sell | 5,189 | $70.29 | $364.7K | 0 |
| Sep 2, 2025 | Maduck Sean | See Remarks | Sell | 20,233 | $70.50 | $1.43M | 0 |
| Sep 2, 2025 | Mokari Atabak | Chief Financial Officer | Sell | 144 | $71.38 | $10.3K | 0 |